SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-219618
Filing Date
2023-08-24
Accepted
2023-08-24 08:32:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d527512ds3.htm S-3 150788
2 EX-5.1 d527512dex51.htm EX-5.1 12371
3 EX-23.1 d527512dex231.htm EX-23.1 2347
4 EX-FILING FEES d527512dexfilingfees.htm EX-FILING FEES 16199
5 GRAPHIC g527512g01a01.jpg GRAPHIC 36528
6 GRAPHIC g527512g0823032925200.jpg GRAPHIC 2335
7 GRAPHIC g527512g09r77.jpg GRAPHIC 3033
  Complete submission text file 0001193125-23-219618.txt   237313
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274182 | Film No.: 231199014
SIC: 3841 Surgical & Medical Instruments & Apparatus